Ranitidine dosage guidelines
Pro Research Analysisby 
Searched over 200M research papers
Ranitidine Dosage Guidelines for Adults
Standard Dosage for Reflux Oesophagitis and Erosive Esophagitis
The most commonly recommended adult dosage for ranitidine in the treatment of reflux oesophagitis and erosive esophagitis is 150 mg twice daily (b.d.) or 150 mg four times daily (q.d.s.)Johnson1989Silver1996Ar1993+1 MORE. Studies show that both 150 mg b.d. and 150 mg q.d.s. are effective, but higher frequency dosing (q.d.s.) may result in higher healing rates and faster symptom reliefJohnson1989Silver1996Ar1993. For more severe cases, higher doses such as 300 mg twice daily (b.d.) or 300 mg four times daily (q.d.s.) have also been used, with increased efficacy but similar safety profilesJohnson1989Silver1996Ar1993.
Alternative Dosage Regimens
Ranitidine 300 mg b.d. is also effective and may be considered as an alternative to 150 mg q.d.s., especially for patients who prefer less frequent dosing. Both regimens are well-tolerated and can be chosen based on patient preference and clinical responseSilver1996Ar1993.
Intravenous Ranitidine in Hospitalized and Critically Ill Patients
For stress ulcer prophylaxis in hospitalized adults, intravenous ranitidine is often administered at 50 mg every 8 to 12 hours (totaling 100–150 mg/day), or as a continuous infusion. In critically ill patients, a daily dose of 200 mg intravenously has been shown to be effective, and increasing the dose to 300 mg/day does not provide additional benefit in maintaining gastric pH. Continuous infusion regimens of 0.125 mg/kg/h are generally sufficient, but higher doses (0.25 mg/kg/h) may be needed for patients with multiple risk factors. These regimens are effective in maintaining gastric pH above 4, which is important for ulcer preventionNoseworthy1987Marchant1988.
Dosage Adjustments in Special Populations
Patients with Chronic Kidney Disease
Ranitidine dosage should be adjusted in patients with chronic kidney disease (CKD). Over half of ranitidine prescriptions in CKD patients were found to be in line with renal dosing guidelines, which typically recommend dose reduction to prevent drug accumulation and adverse effects.
Pediatric Patients
In children, the recommended intravenous ranitidine dose is 2–4 mg/kg/day. However, evidence suggests that a minimum of 3 mg/kg/day is needed to achieve adequate gastric pH control in critically ill pediatric patients. Doses should be titrated to maintain a gastric pH of 4 or higher.
Common Dosage Forms and Frequencies
Oral ranitidine is commonly prescribed as 150 mg tablets taken twice daily. Intravenous ranitidine is often given as 50 mg/2 ml every 12 hours for stress ulcer prophylaxis in hospitalized patients. These regimens are consistent with established guidelines and are widely used in clinical practice.
Conclusion
Ranitidine is typically dosed at 150 mg twice daily or four times daily for adults with reflux oesophagitis or erosive esophagitis, with higher doses reserved for more severe cases. Intravenous dosing in hospitalized or critically ill patients is usually 200 mg/day, with adjustments for renal impairment and pediatric patients. Both oral and intravenous regimens are effective and well-tolerated, and dosing should be tailored to individual patient needs and risk factorsJohnson1989Noseworthy1987Silver1996+6 MORE.
Sources and full results
Most relevant research papers on this topic
Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.
300 mg ranitidine q.d.s. provides faster symptom relief and healing in reflux oesophagitis patients compared to 150 mg ranitidine b.d.
Impact of Pharmacy Efforts to Promote the Optimal Use of Ranitidine in a University Teaching Hospital
A hospital-wide pharmacy-initiated educational program effectively improved ranitidine prescribing patterns, decreased costs, and may serve as a model for addressing other medication usage concerns.
Ranitidine 300 mg twice daily and 150 mg four‐times daily are effective in healing erosive oesophagitis.
Ranitidine 300 mg twice daily is effective in healing erosive oesophagitis and may be an alternative to 150 mg four-times daily in some patients.
Ranitidine is effective therapy for erosive esophagitis.
Ranitidine 150 mg or 300 mg administered four times daily effectively heals and relieves symptoms of erosive esophagitis, with similar safety profiles to placebo.
Gastric pH control in critically ill children receiving intravenous ranitidine.
The minimum dose of 2 to 4 mg/kg/day of intravenous ranitidine in pediatric drug dosage handbooks is inadequate for successful gastric pH control in critically ill children.
Pola penggunaan ranitidine pada pasien HIV & AIDS di UPIPI RSUD Dr. Soetomo Surabaya
Ranitidine is widely used for stress ulcer prophylaxis therapy in HIV & AIDS patients at UPIPI RSUD Dr. Soetomo Surabaya, with a dose of 50mg / 2ml and oral 150mg / tablet, in accordance with existing guidelines.
DOI